Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This typically reflects minor updates or fixes applied to the page content or documentation.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page footer no longer shows branding lines for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with the 'Helpful Links Provided by' label. This changes how the sponsoring institution is presented and credited on the page.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.5.4 replaces Revision: v3.5.3 on the page, signaling a behind-the-scenes software update. This change does not affect the study details or how the page presents information.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting an update to the site’s release/version without changing the underlying ClinicalTrials.gov study content.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.